Adherence to botulinum toxin therapy in female patients with idiopathic overactive bladder: a 48-month real-world observational study : urology

Purpose To evaluate therapy adherence rates in female patients with idiopathic overactive bladder (iOAB) undergoing therapy with 100AE botulinum toxin A over a 4-year follow-up period. Methods All female patients who received their first intravesical injection of 100AE botulinum toxin A for iOAB at...

Full description

Saved in:
Bibliographic Details
Main Authors: Nestler, Sebastian (Author) , Grüne, Britta (Author) , Schilchegger, Lydia (Author) , Neisius, Andreas (Author)
Format: Article (Journal)
Language:English
Published: 12 April 2025
In: International urology and nephrology
Year: 2025, Volume: 57, Issue: 10, Pages: 3199-3206
ISSN:1573-2584
DOI:10.1007/s11255-025-04508-z
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11255-025-04508-z
Verlag, lizenzpflichtig, Volltext: http://link.springer.com/article/10.1007/s11255-025-04508-z
Get full text
Author Notes:Sebastian Nestler, Britta Grüne, Lydia Schilchegger, Andreas Neisius

MARC

LEADER 00000caa a2200000 c 4500
001 1928901093
003 DE-627
005 20251117113631.0
007 cr uuu---uuuuu
008 250623s2025 xx |||||o 00| ||eng c
024 7 |a 10.1007/s11255-025-04508-z  |2 doi 
035 |a (DE-627)1928901093 
035 |a (DE-599)KXP1928901093 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Nestler, Sebastian  |d 1981-  |e VerfasserIn  |0 (DE-588)137011954  |0 (DE-627)622563033  |0 (DE-576)320854876  |4 aut 
245 1 0 |a Adherence to botulinum toxin therapy in female patients with idiopathic overactive bladder  |b a 48-month real-world observational study : urology  |c Sebastian Nestler, Britta Grüne, Lydia Schilchegger, Andreas Neisius 
264 1 |c 12 April 2025 
300 |b Diagramme 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.06.2025 
520 |a Purpose To evaluate therapy adherence rates in female patients with idiopathic overactive bladder (iOAB) undergoing therapy with 100AE botulinum toxin A over a 4-year follow-up period. Methods All female patients who received their first intravesical injection of 100AE botulinum toxin A for iOAB at a single centre between January 2018 and December 2020 were evaluated over a 48-month follow-up for treatment benefit, reduction of urgency incontinence episodes, bladder capacity, repeat injections, adverse events, adherence to therapy, and reasons for discontinuation. Results A total of 106 women met our inclusion criteria and 15 were excluded. Of the remaining 91 women, the mean age before the first injection was 64 years and the median urinary incontinence episodes (UIE) was 3.6. After 48 months, 64 patients (70.3%) continued the therapy. Bladder capacity increased by a median of 105-207 cc and the UIE was reduced by 2.64 episodes daily. Complete continence was achieved in 31 patients (34.1%). After the second cycle, 71 patients (78.0%) were satisfied with therapy, with similar results in subsequent cycles. In addition, most patients who adhered to the therapy received four or five rounds of treatments. Adverse events were mainly urinary tract infections (11.8%) in the first cycle and less in subsequent cycles. No de novo clean intermittent self-catheterisation was detected. The reasons for discontinuation among the 27 patients who discontinued therapy were diverse and mostly unmet expectations. Conclusions Female patients with iOAB had good therapy adherence to botulinum toxin A, evidenced by stable improvements in UIE and bladder capacity and high rates of satisfaction in patients’ self-assessment. 
700 1 |a Grüne, Britta  |e VerfasserIn  |0 (DE-588)1233692895  |0 (DE-627)1758052597  |4 aut 
700 1 |a Schilchegger, Lydia  |e VerfasserIn  |4 aut 
700 1 |a Neisius, Andreas  |d 1978-  |e VerfasserIn  |0 (DE-588)139036199  |0 (DE-627)607776692  |0 (DE-576)309666244  |4 aut 
773 0 8 |i Enthalten in  |t International urology and nephrology  |d Dordrecht [u.a.] : Springer Science + Business Media B.V., 1970  |g 57(2025), 10, Seite 3199-3206  |h Online-Ressource  |w (DE-627)320529134  |w (DE-600)2015547-5  |w (DE-576)263021106  |x 1573-2584  |7 nnas  |a Adherence to botulinum toxin therapy in female patients with idiopathic overactive bladder a 48-month real-world observational study : urology 
773 1 8 |g volume:57  |g year:2025  |g number:10  |g pages:3199-3206  |g extent:8  |a Adherence to botulinum toxin therapy in female patients with idiopathic overactive bladder a 48-month real-world observational study : urology 
856 4 0 |u https://doi.org/10.1007/s11255-025-04508-z  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://link.springer.com/article/10.1007/s11255-025-04508-z  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250623 
993 |a Article 
994 |a 2025 
998 |g 1233692895  |a Grüne, Britta  |m 1233692895:Grüne, Britta  |d 60000  |d 63100  |e 60000PG1233692895  |e 63100PG1233692895  |k 0/60000/  |k 1/60000/63100/  |p 2 
999 |a KXP-PPN1928901093  |e 4737698954 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","display":"Nestler, Sebastian","roleDisplay":"VerfasserIn","given":"Sebastian","family":"Nestler"},{"family":"Grüne","given":"Britta","roleDisplay":"VerfasserIn","display":"Grüne, Britta","role":"aut"},{"role":"aut","display":"Schilchegger, Lydia","roleDisplay":"VerfasserIn","given":"Lydia","family":"Schilchegger"},{"given":"Andreas","family":"Neisius","role":"aut","display":"Neisius, Andreas","roleDisplay":"VerfasserIn"}],"title":[{"title":"Adherence to botulinum toxin therapy in female patients with idiopathic overactive bladder","subtitle":"a 48-month real-world observational study : urology","title_sort":"Adherence to botulinum toxin therapy in female patients with idiopathic overactive bladder"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 23.06.2025"],"language":["eng"],"recId":"1928901093","name":{"displayForm":["Sebastian Nestler, Britta Grüne, Lydia Schilchegger, Andreas Neisius"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"12 April 2025"}],"id":{"eki":["1928901093"],"doi":["10.1007/s11255-025-04508-z"]},"physDesc":[{"extent":"8 S.","noteIll":"Diagramme"}],"relHost":[{"pubHistory":["Volume 2, issue 1 (March 1970)-"],"part":{"extent":"8","text":"57(2025), 10, Seite 3199-3206","volume":"57","pages":"3199-3206","issue":"10","year":"2025"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 06.03.25"],"disp":"Adherence to botulinum toxin therapy in female patients with idiopathic overactive bladder a 48-month real-world observational study : urologyInternational urology and nephrology","recId":"320529134","language":["eng"],"title":[{"title_sort":"International urology and nephrology","title":"International urology and nephrology"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedDisp":"1970-","publisher":"Springer Science + Business Media B.V. ; Kluwer","dateIssuedKey":"1970"}],"id":{"zdb":["2015547-5"],"eki":["320529134"],"issn":["1573-2584"]}}]} 
SRT |a NESTLERSEBADHERENCET1220